Investors

Business Description

Cloudtag Inc’s main focus is based on a B2B SaaS business model utilising its proprietary device – the Onitor and algorithms remotely recording and analysing heart rate and variable heart rate along with energy expansion (Kcal) readings of overweight persons with the primary objective of reducing the propensity of an overweight - obese person attracting type 2 diabetes. Type 2 diabetes represents the highest financial burden of any health care provider be it national or private one. Type 2 diabetes is a lifelong chronic disease. The platform allows the individual to better manage their health and wellness goals and keep track of their progress.

The current commercial focus for the platform is to remotely diagnose the individual’s nutritional & physical outputs with the primary aim of pre-surgical procedure: drawing the individual into the weight range they need to reach in order for the medical reimbursement scheme to be applied.

Cloudtag Inc is incorporated in St Vincent and operates in a number of jurisdictions.

Company Directors

Amit Ben-Haim
(Chief Executive Officer)

Amit Ben-Haim has a proven track record as a successful entrepreneur establishing, leading and expanding companies through to trade sale exits as co-founder, executive and non-executive director. In 1993, he co-founded Biosense Inc., a medical devices company which was sold to Dow Jones-listed Johnson & Johnson in 1997 for $485 million. In 1996, he co-established Impulse Dynamics Inc., another medical devices company, which ultimately licensed its cardiac contractility technology to NYSE-listed Guidant Corporation (a group company of Boston Scientific) and in 1998 he was one of several founders of Odigo Inc., a communications company specialising in instant messaging platforms (for example Blackberry’s BBM) which was sold in 2002 to NASDAQ-listed Comverse Inc. Amit’s experience extends across various industries including aviation (private and commercial), infrastructure, corporate finance and wealth management. He has expertise in risk and regulatory compliance for listed companies and is a director of SB Corporate Finance Partners Limited which is authorised by the Financial Conduct Authority to advise on and/or arrange certain investments in the UK.


Directors Responsibilities

Board Meetings
The Board will meet approximately quarterly, more often if required. The matters reserved for the attention of the Board include:
  • The approval of financial statements, dividends and significant changes in accounting practices;
  • Board membership and powers including the appointment and removal of Board members, determining the terms of reference of the Board and establishing the overall control framework;
  • Communications with shareholders;
  • Senior management and subsidiary board appointments and remuneration, contracts and the grant of share options;
  • Key commercial matters including consideration of potential product developments, target markets and pricing strategies;
  • Financial matters including: the approval of the budget and financial plans, changes to the Group’s capital structure, the Group’s business strategy, investment commitments and capital expenditure, and the entering into of any arrangement or agreement with a shareholder or any associate of a shareholder holding over 3.0% per cent of the share capital;
  • The strategy for procuring funding either through equity or loans, for the Group’s operations and the implementation of that strategy;
  • Other matters including health and safety policy, insurance and legal compliance; and
  • strategic matters such as potential business combinations.
A core element of financial control is tight control of cash resources.
Internal Controls
The Board is committed to the maintenance of effective internal controls. The Board recognises its responsibility to review and consider the system of controls in place for itself and its subsidiary undertakings. The controls to be put in place for the Group will be the subject of regular review. The Group has adopted strict anti-bribery and corruption policies and seeks to enforce these through a variety of means. A detailed manual of policies and procedures has been prepared and a copy has been given to all directors and key executives. This manual contains a statement of the Company policy and sets out in detail the procedures to be adopted to pre-approve contract counterparties, conduct formal and open tender processes, formulate decisions in a fair manner and authorise payments. The manual contains standard formats for application forms and required confirmations of adoption of anti-corruption policies to be signed by third parties with whom the Company will enter into contracts. The Board is committed to maintaining high standards of corporate governance. Other than the arrangements noted above, no further corporate governance code has been adopted by the Company.

Incorporation

Constitutional Documents

Cloudtag Inc’s main focus is based on a B2B SaaS business model utilising its proprietary device – the Onitor and algorithms remotely recording and analysing heart rate and variable heart rate along with energy expansion (Kcal) readings of overweight persons with the primary objective of reducing the propensity of an overweight - obese person attracting type 2 diabetes. Type 2 diabetes represents the highest financial burden of any health care provider be it national or private one. Type 2 diabetes is a lifelong chronic disease. The platform allows the individual to better manage their health and wellness goals and keep track of their progress.

The current commercial focus for the platform is to remotely diagnose the individual’s nutritional & physical outputs with the primary aim of pre-surgical procedure: drawing the individual into the weight range they need to reach in order for the medical reimbursement scheme to be applied.

Cloudtag Inc is incorporated in St Vincent and operates in a number of jurisdictions.

 


By Laws

Securities Information

Significant Shareholders

Name Designation Shares %
AMIT BEN HAIM 162,894,143 21.65%
HARGREAVES LANSDOWN (NOMINEES) LIMITED HLNOM 44,970,608 5.98%
HARGREAVES LANSDOWN (NOMINEES) LIMITED 15,942 44,961,419 5.98%
OSUNA LIMITED 30,975,000 4.12%
HARGREAVES LANSDOWN (NOMINEES) LIMITED VRA 30,903,667 4.11%
MR MIKE HIRSCHFIELD 12,335,834 3.37%
LYNCHWOOD NOMINEES LIMITED 2,006,420 25,198,262 3.35%

The Company has 752,282,424 shares in issue at the date of this update, 04/10/19.

Financial Reports and Circulars

Cloudtag Circular

CloudTag Inc. announced on 7 November 2016 that the Company has conditionally agreed with an overseas Institutional Investor, L1 Capital Global Opportunities Master Fund (“L1”), to issue up to £4,500,000 Senior Unsecured Zero Coupon Convertible Notes to raise gross proceeds of up to £4.05 million.

Half Year Results for the six month period ended 31 March 2016

CloudTag (CTAG:LN), the company that brings personal monitoring to the health, wellbeing and fitness markets is pleased to announce its interim results for the six months ended 31 March 2016.

30/03/16: Annual Report and Accounts

On the 30th of March, 2016, CloudTag released the company financial report and accounts for the year ended 30th September 2015.

26/06/2015: Half Yearly Report

On the 26 June, 2015, CloudTag announced their half yearly report.

30/03/2015: Annual Report

On the 30th of March, 2015, CloudTag released the company financial report and accounts for the year ended 30th September 2014.

04/12/2014: Notice of EGM and Issue of Loan Notes

On the 4th of December, 2014, CloudTag announced the succesful raise of £800,000, read the notes here as well as the notice of the comapny EGM.

04/12/2014: Form of Instruction for EGM

Download your form of instuction for the upcoming EGM here.

04/12/2014: Proxy Form of Instruction for EGM

Download your proxy form of instuction for the upcoming EGM here.

30/05/2014: HALF YEAR RESULTS

On the 30th of May, 2014, CloudTag announced it's Half Year Results for the six month period ended 31 March 2014.

31/03/2014: ANNUAL REPORTS & ACCOUNTS AND NOTICE OF AGM

On the 31st of March, 2014, CloudTag announced it’s Annual Reports & Accounts.

28/06/2013: HALF YEARLY REPORT

On the 28th of June, 2013, CloudTag announced it’s Half Yearly report.

20/03/2013: ADMISSION DOCUMENT

The company listed on the AIM market on Wednesday the 20th of March 2013.

01/03/2013: COMPANY 10 DAY ANNOUNCEMENT

The company applied to list on the AIM market and received the 10 day announcement on the 1st of March 2013.

Company Advisers

(Accountants)

Hazlewoods LLP

Windsor House

Bayshill Road

Cheltenham

GL50 3AT

(Registrar)

Computershare

Investor Service

(Cayman) Limited

Windward 1

Regatta O

West Bay Road

Grand Cayman KY1-1103

Cayman Islands